Novartis cuts 275 jobs at Illinois site to consolidate Zolgensma manufacturing in North Carolina
As Novartis continues to reshape itself, the company is shutting the doors to one of its gene therapy manufacturing sites in the US.
The closure …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
